´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021 : 2021-02-20±³À°ÀÏÀÚ : 2021-02-20
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021 ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ½ÅÀåÇÐȸ»ç¹«±¹
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í 1Àϵî·Ï½Ã 50,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 20ÀÏ 09:10~09:40 Key issues in the management of electrolyte and acid-base disorders ±è±ÙÈ£(ÇѾçÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 09:40~10:10 Calcium metabolism in general population and kidney disease patients: an overview ¹èÀºÈñ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 10:10~10:40 Proper use of diuretics: oldies but goodies À¯°æµ·(¿ï»êÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 10:50~11:20 The role of continuous renal replacement therapy in sepsis-induced AKI Á¶ÀåÈñ(°æºÏÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 11:20~11:50 AKI in patients with hepatic failure: hepatorenal syndrome vs. septic AKI ÃÖÈÆ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 11:50~12:20 Fluid and nutritional management of AKI patients: during vs. after CRRT ÀåÇý·Ã(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 13:20~13:50 Glomerular disease: evaluation and differential diagnosis ¹®ÁÖ¿µ(°æÈñÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 13:50~14:20 Evidence-based clinical practice guidelines for nephrotic syndrome ¼Û»óÇå(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 14:20~14:50 Overview of the classification and treatment of crescentic glomerulonephritis ÁøÈ£ÁØ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 14:50~15:20 Differential diagnosis and treatment of thrombotic microangiopathies ÃÖ´ëÀº(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 15:30~16:00 Transplant immunobiology ÀÌÁ¾¼ö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 16:00~16:30 Immunologic test & monitoring in kidney transplant recipients ±è¹ü¼®(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 16:30~17:00 Recent advances in evaluation & management for transplant rejection Çѽ¿±(°è¸íÀÇ´ë)
±³À°½Ã°£ 02¿ù 20ÀÏ 17:00~17:30 ABO-incompatible KT & HLA-incompatible KT: update ¾çö¿ì(°¡Å縯ÀÇ´ë)